Shifting payment models based on quality and value are fueling the demand for comprehensive insights into the health of patient populations.
The provider and payer markets are in the midst of a huge transformation, and 60% of commercial plans already link payments to value.
Meanwhile, the Department of Health and Human Services is pushing to tie 50% of traditional fee-for-service payments to quality measures by 2018.
Both providers and payers are focused on improving health at the patient level through better care coordination, especially for chronic conditions like diabetes and obesity.
To impact outcomes at the patient level, stakeholders need an in-depth understanding of outcomes within populations.
The advent of precision medicine is also aiding efforts and providing opportunities to connect genetic details with the environmental and lifestyle factors that affect the health of individuals.
To download the whitepaper, you will first need to fill out a short webform: